Inventor · disambiguated record
Peter Glazer
Also filed as: GLAZER PETER · GLAZER PETER M
19 granted patents·32 pending applications·301 citations·filing 1995–2024
94Inventor score
Top patents by PatentIndex Score
51 records- 0194US11872286B2Compositions and methods for delivery of nucleic acids to cellsUNIV YALE·Filed 2022·Granted Jan 16, 2024·2 cites·17 claims
- 0294US11850284B2Compositions and methods for delivery of nucleic acids to cellsUNIV YALE·Filed 2022·Granted Dec 26, 2023·2 cites·22 claims
- 0392US12005121B2Compositions and methods for delivery of nucleic acids to cellsUNIV YALE·Filed 2022·Granted Jun 11, 2024·1 cites·22 claims
- 0491US9701740B2Cell-penetrating anti-DNA antibodies and uses thereof inhibit DNA repairHANSEN JAMES E·Filed 2012·Granted Jul 11, 2017·12 cites·32 claims
- 0590US11136597B2Compositions for enhancing targeted gene editing and methods of use thereofUNIV YALE·Filed 2017·Granted Oct 5, 2021·10 cites·30 claims
- 0690US8309356B2Pseudocomplementary oligonucleotides for targeted gene therapyGLAZER PETER M·Filed 2010·Granted Nov 13, 2012·20 cites·21 claims
- 0790US5962426ATriple-helix forming oligonucleotides for targeted mutagenesisUNIV YALE·Filed 1995·Granted Oct 5, 1999·100 cites·11 claims
- 0888US7279463B2Triple-helix forming oligonucleotides for targeted mutagenesisUNIV YALE·Filed 2001·Granted Oct 9, 2007·20 cites·10 claims
- 0986US8658608B2Modified triple-helix forming oligonucleotides for targeted mutagenesisGLAZER PETER M·Filed 2006·Granted Feb 25, 2014·24 cites·23 claims
- 1085US2024285775A1Compositions and methods for delivery of nucleic acids to cellsUNIV YALE·Filed 2023·Application pending·0 cites
- 1184US9346846B1Anti-cancer compounds and methods for treating cancerUNIV YALE·Filed 2014·Granted May 24, 2016·5 cites·8 claims
- 1284US7078389B2Chemically modified oligonucleotide for site-directed mutagenesisUNIV YALE·Filed 2001·Granted Jul 18, 2006·19 cites·9 claims
- 1384US2024285774A1Compositions and methods for delivery of nucleic acids to cellsUNIV YALE·Filed 2023·Application pending·0 cites
- 1483US10961301B2Cell-penetrating anti-DNA antibodies and uses thereof inhibit DNA repairUNIV YALE·Filed 2017·Granted Mar 30, 2021·1 cites·20 claims
- 1583US2024247056A1Cell-penetrating anti-dna antibodies and uses thereof inhibit dna repairUNIV YALE·Filed 2024·Application pending·0 cites
- 1678US2022227885A1Methods for dna-depending targeting of a cell permeant antibodyUNIV YALE·Filed 2021·Application pending·0 cites
- 1777US6303376B1Methods of targeted mutagenesis using triple-helix forming oligonucleotidesUNIV YALE·Filed 1999·Granted Oct 16, 2001·35 cites·12 claims
- 1876US5776744AMethods and compositions for effecting homologous recombinationUNIV YALE·Filed 1995·Granted Jul 7, 1998·50 cites·34 claims
- 1974US12485180B2Compositions and methods for delivery of nucleic acids to cellsUNIV YALE·Filed 2020·Granted Dec 2, 2025·0 cites·9 claims
- 2070US2022017609A1Cell-penetrating anti-dna antibodies and uses thereof inhibit dna repairUNIV YALE·Filed 2021·Application pending·0 cites
- 2169US2020129636A1Methods for dna-dependent targeting of a cell permeant antibodyUNIV YALE·Filed 2019·Application pending·0 cites
- 2268US2023277658A1Compositions and methods for enhancing triplex and nuclease-based gene editingUNIV YALE·Filed 2022·Application pending·0 cites
- 2365US2025170259A1Compositions and methods for delivering therapeutic polynucleotides for exon skippingUNIV YALE·Filed 2023·Application pending·0 cites
- 2463US2023272115A1Compositions and methods for enhancing donor oligonucleotide-based gene editingUNIV YALE·Filed 2022·Application pending·0 cites
- 2563US2023303719A1Humanized 3e10 antibodies, variants, and antigen binding fragments thereofUNIV YALE·Filed 2023·Application pending·0 cites
- 2662US2021338815A1Compositions and methods for enhancing triplex and nuclease-based gene editingUNIV YALE·Filed 2019·Application pending·0 cites
- 2762US2025161484A1Compositions and methods for treating diseaseUNIV YALE·Filed 2023·Application pending·0 cites
- 2860US2025127917A1Compositions and methods for treating cancersUNIV YALE·Filed 2022·Application pending·0 cites
- 2959US2024181086A1Compositions and methods for delivering therapeutic polynucleotidesUNIV YALE·Filed 2022·Application pending·0 cites
- 3059US2024216530A1Compositions and Methods for Treating Skeletal Muscle DiseaseUNIV YALE·Filed 2022·Application pending·0 cites
- 3158US12441814B2Compositions and methods for enhancing donor oligonucleotide-based gene editingUNIV YALE·Filed 2019·Granted Oct 14, 2025·0 cites·19 claims
- 3257US2024279687A1Peptide nucleic acids for spatiotemporal control of crispr-cas bindingUNIV YALE·Filed 2022·Application pending·0 cites
- 3357US2024190998A1Compositions and methods for delivery of nucleic acids to cellsUNIV YALE·Filed 2021·Application pending·0 cites
- 3454US2022372474A1Hydroxymethyl-modified gamma-pna compositions and methods of use thereofUNIV YALE·Filed 2020·Application pending·0 cites
- 3553US2022243211A1Peptide nucleic acid compositions with modified hoogsteen binding segments and methods of use thereofUNIV YALE·Filed 2020·Application pending·0 cites
- 3652US12496357B2Compositions and methods for treating sickle cell diseaseUNIV YALE·Filed 2020·Granted Dec 16, 2025·0 cites·19 claims
- 3751US2021189431A1Compositions and methods for embryonic gene editing in vitroUNIV YALE·Filed 2019·Application pending·0 cites
- 3850US2022339294A1Nanoparticles for selective tissue or cellular uptakeUNIV YALE·Filed 2020·Application pending·0 cites
- 3950US2023265214A1Compositions and methods for delivery of nucleic acids to cellsUNIV YALE·Filed 2021·Application pending·0 cites
- 4049US7407752B2Oligonucleotide complexes for use as anti-viral therapeuticsUNIV UTAH RES FOUND·Filed 2004·Granted Aug 5, 2008·0 cites·3 claims
- 4149US2016271156A1Anti-cancer compounds and methods for treating cancerUNIV YALE·Filed 2016·Application pending·0 cites
- 4248US2020113821A1Compositions and methods for in utero deliveryUNIV YALE·Filed 2018·Application pending·0 cites
- 4348US2003148352A1Intracellular generation of single-stranded DNAUNIV YALE·Filed 2002·Application pending·0 cites
- 4445US11311538B2Compositions and methods for targeting cancersUNIV YALE·Filed 2019·Granted Apr 26, 2022·0 cites·15 claims
- 4545US2021340279A1Compositions and methods of using cell-penetrating antibodies in combination with immune checkpoint modulatorsUNIV YALE·Filed 2019·Application pending·0 cites
- 4637US2020308590A1Compositions and methods for treatment of cystic fibrosisUNIV YALE·Filed 2017·Application pending·0 cites
- 4737US2010172882A1Compositions and methods for targeted inactivation of hiv cell surface receptorsGLAZER PETER M·Filed 2008·Application pending·0 cites
- 4836US2011268810A1Polymeric materials loaded with mutagenic and recombinagenic nucleic acidsUNIV YALE·Filed 2010·Application pending·0 cites
- 4936US2019133980A1Compositions and methods for targeting and treating homologous recombination-deficient tumorsUNIV YALE·Filed 2017·Application pending·0 cites
- 5029US2011262406A1Compositions and methods for targeted inactivation of hiv cell surface receptorsUNIV YALE·Filed 2011·Application pending·0 cites
Showing the top 50 of 51 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →